Evaluating the clinical feasibility: The direct bisulfite genomic sequencing for examination of methylated status of protocadherin10 (PCDH10) promoter to predict the prognosis of gastric cancer

To elucidate the clinical significance of the methylated status of CpG site count of PCDH10 promoter in the survival prediction in gastric cancer (GC). In the previous study, we demonstrated that the methylated CpG site count was significantly associated with the overall survival (OS) of GC patients...

Ausführliche Beschreibung